VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.

ABSTRACT:

SUBMITTER: Lopes-Aguiar L 

PROVIDER: S-EPMC5520405 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature